Download PDF
Zeitschrift für Phytotherapie 2018; 39(04): 191-200
DOI: 10.1055/a-0654-0563
Porträt
© Georg Thieme Verlag KG Stuttgart · New York

Tee – weit mehr als ein Getränk?

Karen Nieber
Further Information

Publication History

Publication Date:
04 September 2018 (online)

    Permissions and Reprints

Zusammenfassung

Tee trinken gehört seit Jahrtausenden zur menschlichen Geschichte. Tee war schon im alten China als Heilmittel bekannt und wurde im Lauf der Zeit zum alltäglichen Getränk. Tee ist ein Supercocktail mit vielfältigen Wirkungen. Obwohl die Inhaltsstoffe des Tees, besonders das Koffein und die Polyphenole, in vitro antioxidative, entzündungshemmende, antimikrobielle, antikarzinogene, blutdrucksenkende, neuroprotektive, cholesterinsenkende und thermogene Eigenschaften besitzen, sind die Ergebnisse am Menschen bisher sehr heterogen und nur in durch wenige Studien mit geringen Patientenzahlen belegt. Der Artikel gibt einen Überblick über klinische Studien zur Wirkung von schwarzem und grünem Tee bei Herz-Kreislauf-Erkrankungen, Krebs, Hauterkrankungen sowie Wirkungen auf das Körperfett.

Abstract

Tea - far more than a drink?

Drinking tea has been considered a health-promoting habit since ancient times. The modern medicinal research is providing a scientific basis for this belief. Encouraging data showing cancer-preventive effects of green tea from cell-culture, animal and human studies have emerged. Evidence is accumulating that black tea may have similar beneficial effects. Tea consumption has also been shown to be useful for prevention of many debilitating human diseases that include maintenance of cardiovascular and metabolic health. Various studies suggest that polyphenolic compounds present in green and black tea are associated with beneficial effects in prevention of cardiovascular diseases, particularly of atherosclerosis and coronary heart disease. Evidence is accumulating that catechins, especially (−)-epigallocatechin-3-gallate (EGCG), which is the main polyphenolic compound of green and black tea, respectively, are responsible for most of the physiological effects of tea. Encouraging data from many trials are available. However, results from human studies are not always positive, which may be due to the fact that in animal studies higher doses of tea are used than those consumed by humans and also, that in animal studies the experimental conditions are generally optimized for the evaluation of a protective effect. Large-scale well-controlled human clinical trials are necessary to establish the postulated health promoting effects of tea consumption. Based on these findings, recommendations to human population could be made.

This article describes the evidences from experimental, clinical and epidemiological studies in the prevention of chronic diseases like cancer, cardiovascular diseases and skin diseases as well as body weight reduction associated with black and green tea consumption.

 

  • Literatur

  • 1 Deutscher Teeverband. Tee als Wirtschaftsfaktor. April 2017 http://www.teeverband.de/fileadmin/user_upload/WFT_2017_DE.pdf . Zugriff 19.06.2018.
    PubMedGoogle Scholar
  • 2 Böttger HB. Teelexikon – Das Nachschlagewerk für alle Teetrinker. Berlin: Pro BUSINESS; 2010
    Google Scholar
  • 3 https://www.zauberdestees.de/die-anbaugebiete-des-tees. Zugriff 20.06.2018
    PubMed
  • 4 https://www.peak.ag/de/classic/peak-blog/theanin-aktive-substanz-in-tee-teil-1. Zugriff 19.03.2018.
    PubMed
  • 5 Wang Y, Ho CT. Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem 2009; 57: 8109-8114
    CrossrefPubMedGoogle Scholar
  • 6 Hodgson JM, Croft KD. Tea flavonoids and cardiovascular health. Mol Aspects Med 2010; 31: 495-502
    CrossrefPubMedGoogle Scholar
  • 7 Mukamal KJ, MacDermott K, Vinson JA. et al. A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 2007; 154: 724 .e1 – 6
    PubMedGoogle Scholar
  • 8 Schreuder TH, Eijsvogels TM, Greyling A. et al. Effect of black tea consumption on brachial artery flow-mediated dilatation and ischemia-reperfusion in humans. Appl Physiol Nutr Metab 2014; 39: 145-151
    CrossrefPubMedGoogle Scholar
  • 9 Greyling A, Ras RT, Zock PL. et al. The effect of black tea on blood pressure: a systematic review with meta-analysis of randomized controlled trials. PLoS One 2014; 9 (07) e103247
    CrossrefPubMedGoogle Scholar
  • 10 Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 2010; 12: 448-455
    CrossrefPubMedGoogle Scholar
  • 11 Wang ZM, Zhou B, Wang YS. et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr 2011; 93: 506-515
    CrossrefPubMedGoogle Scholar
  • 12 Peng X, Zhou R, Wang B. et al. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep 2014; 4: 6251
    PubMedGoogle Scholar
  • 13 Ikeda M, Suzuki C, Umegaki K. et al. Preventive effects of green tea catechins on spontaneous stroke in rats. Med Sci Monit 2007; 13: BR40-45
    PubMedGoogle Scholar
  • 14 Potenza MA, Marasciulo FL, Tarquinio M. et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I / R injury in SHR. Am J Physiol Endocrinol Metab 2007; 292: E1378-1387
    CrossrefPubMedGoogle Scholar
  • 15 Bhardwaj P, Khanna D. Green tea catechins: defensive role in cardiovascular disorders. Chin J Nat Med 2013; 11: 345-353
    PubMedGoogle Scholar
  • 16 Babu PV, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem 2008; 15: 1840-1850
    CrossrefPubMedGoogle Scholar
  • 17 Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007; 81: 519-533
    CrossrefPubMedGoogle Scholar
  • 18 Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009; 9: 429-439
    CrossrefPubMedGoogle Scholar
  • 19 Kanwar J, Taskeen M, Mohammad I. et al. Recent advances on tea polyphenols. Front Biosci 2012; 4: 111-131
    PubMedGoogle Scholar
  • 20 Lambert JD. Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am J Clin Nutr 2013; 98 ( 6Suppl .): 1667S-1675S
    CrossrefPubMedGoogle Scholar
  • 21 Butt MS, Ahmad RS, Sultan MT. et al. Green tea and anticancer perspectives: updates from last decade. Crit Rev Food Sci Nutr 2015; 55: 792-805
    CrossrefPubMedGoogle Scholar
  • 22 Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr 2013; 32: 894-903
    CrossrefPubMedGoogle Scholar
  • 23 Nam S, Smith DM, Dou QP. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001; 276: 13322-13330
    CrossrefPubMedGoogle Scholar
  • 24 Jatoi A, Ellison N, Burch PA. et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003; 97: 1442-1446
    CrossrefPubMedGoogle Scholar
  • 25 Luo H, Tang L, Tang M. et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: Modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 2006; 27: 262-268
    CrossrefPubMedGoogle Scholar
  • 26 Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009; 9: 429-439
    CrossrefPubMedGoogle Scholar
  • 27 Granja A, Pinheiro M, Reis S. Epigallocatechin gallate nanodelivery systems for cancer therapy. Nutrients 2016; 8 : pii: E307
    CrossrefPubMedGoogle Scholar
  • 28 Oyetakin-White P, Tribout H, Baron E. Protective mechanisms of green tea polyphenols in skin. Oxid Med Cell Longev 2012; 2012: 560682
    PubMedGoogle Scholar
  • 29 Vayalil PK, Elmets CA, Katiyar SK. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003; 24: 927-936
    CrossrefPubMedGoogle Scholar
  • 30 Zink A, Traidl-Hoffmann C. Green tea in dermatology – myths and facts. J Dtsch Dermatol Ges 2015; 13: 768-775
    PubMedGoogle Scholar
  • 31 Moon HS, Lee HG, Choi YJ. et al. Proposed mechanisms of (–)-epigallocatechin-3-gallate for anti-obesity. Chem Biol Interact 2007; 167: 85-98
    CrossrefPubMedGoogle Scholar
  • 32 Pan H, Gao Y, Tu Y. Mechanisms of body weight reduction by black tea polyphenols. Molecules 2016; 21 : pii: E1659
    CrossrefPubMedGoogle Scholar
  • 33 Suzuki T, Pervin M, Goto S. et al. Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity. Molecules 2016; 21 : pii: E1305
    CrossrefPubMedGoogle Scholar
  • 34 Jurgens TM, Whelan AM, Killian L. et al. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev 2012 (12) CD008650
    PubMedGoogle Scholar
  • 35 Yang CS, Zhang J, Zhang L. et al. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res 2016; 60: 160-174
    CrossrefPubMedGoogle Scholar
  • 36 Westerterp-Plantenga MS. Green tea catechins, caffeine and body-weight regulation. Physiol Behav 2010; 100: 42-46
    CrossrefPubMedGoogle Scholar
  • 37 Zijp IM, Korver O, Tijburg LB. Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 2000; 40: 371-398
    CrossrefPubMedGoogle Scholar
  • 38 Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr 2013; 32: 894-903
    CrossrefPubMedGoogle Scholar
  • 39 Qiao J, Gu C, Shang W. et al. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food Chem Toxicol 2011; 49: 1410-1415
    CrossrefPubMedGoogle Scholar
  • 40 Golden EB, Lam PY, Kardosh A. et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009; 113: 5927-5937
    CrossrefPubMedGoogle Scholar
  • 41 Misaka S, Yatabe J, Müller F. et al. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther 2014; 95: 432-438
    CrossrefPubMedGoogle Scholar
  • 42 https://teelux.de/teewiki/wie-viel-tee-sollten-sie-trinken-pro-tag-empfehlungen-der-aerzte/ Zugriff 29.06.2018.
    PubMed
  • 43 Ellinger S, Müller N, Stehle P, Ulrich-Merzenich G. Consumption of green tea or green tea products: is there an evidence for antioxidant effects from controlled interventional studies?. Phytomedicine 2011; 18: 903-915
    CrossrefPubMedGoogle Scholar
  • 44 National Cancer Institute. Tea and Cancer Prevention. https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/tea-fact-sheet
    PubMedGoogle Scholar
  • 45 Tang J, Zheng JS, Fang L. et al. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr 2015; 114: 673-683
    CrossrefPubMedGoogle Scholar
  • 46 Min KJ, Kwon TK. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr Med Res 2014; 3: 16-24
    PubMedGoogle Scholar